Valo Health acquires TARA Biosystems to create integrated cardiovascular platform
The transaction will create a vertically integrated platform and cardiovascular disease franchise, which will support the discovery and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Apr 22
The transaction will create a vertically integrated platform and cardiovascular disease franchise, which will support the discovery and…
11 Mar 22
Xcellomics programme was created by the two Oxford-based institutions to advance the early-stage drug discovery research by academic…
11 Feb 22
The US drugmaker has used several insights from the CytoReason’ platform, in several of its R&D programmes across…
10 Feb 22
The investment round, jointly led by SoftBank Vision Fund 2 and RA Capital Management, will advance the company’s…
23 Dec 21
The acquisition will enable Novartis to add Gyroscope’s investigational gene therapy, GT005, to its portfolio
17 Jun 21
Allcyte’s platform anticipates the activity of cancer treatments using AI to analyse the activity of drugs in live…
20 May 21
The collaboration will deploy AI to advance the discovery of small molecule therapeutic drug candidates in multiple therapeutic…
04 May 21
The transaction will enable Roivant Sciences to become a public entity and is expected to be listed on…
28 Apr 21
Exscientia intends to use the funding to advance its pipeline through clinical testing along with expanding its technology…
04 Mar 21
Exscientia intends to use proceeds from the financing round to further advance AI drug discovery platform and portfolio